Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer. (Q40482551)

20 September 2017

title

Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer. (English)

1 reference

20 September 2017

1 reference

4

Kunle Odunsi

1 reference

20 September 2017

Sameer Sharma

1

1 reference

20 September 2017

Katayoun Rezai

series ordinal

2

1 reference

20 September 2017

Deborah Driscoll

series ordinal

3

1 reference

20 September 2017

Shashikant Lele

series ordinal

5

1 reference

20 September 2017

language of work or name

English

0 references

publication date

30 March 2006

1 reference

20 September 2017

1 reference

20 September 2017

volume

103

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

181-185

1 reference

The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

Granulocyte-macrophage colony stimulating factor prior to chemotherapy for advanced epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

Chemoprophylaxis with ciprofloxacin in ovarian cancer patients receiving paclitaxel: a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

Retrospective review of gynecologic oncology patients with therapy-induced neutropenic fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

Sequences of taxol and cisplatin: a phase I and pharmacologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

Chemotherapy-induced neutropenia and fever in patients receiving cisplatin-based chemotherapy for ovarian malignancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

Advances in the systemic treatment of cancers in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.012

10.1016/J.YGYNO.2006.02.012

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference